Home » Topics » BioWorld Science

BioWorld Science
RSS

Evotec and Takeda enter multi-RNA target alliance

March 23, 2021

Avalon Globocare and MIT expand their codevelopment program

March 23, 2021

FDA approves IND application for CBX-12

March 23, 2021

BioCryst presents successful data from proof-of-concept trial of BCX-9930 in PNH

March 23, 2021

Encouraging preliminary phase I data for RP-L301 in pyruvate kinase deficiency

March 23, 2021

Odonate Therapeutics discontinues development of tesetaxel

March 23, 2021

Terns initiates dosing in first-in-human trial of TERN-501

March 23, 2021

BioAge begins phase II trial of BGE-175 in older patients with COVID-19

March 22, 2021

China NMPA clears start of phase III trial of Endostar for malignant thoracoabdominal effusions

March 22, 2021

U.S. phase III trial of AZD-1222 for COVID-19 meets primary efficacy endpoint at interim analysis

March 22, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...